James N. Wilson, Director at CORCEPT THERAPEUTICS INC (CORT), sold 10,000 shares at $114.48 ($1.1M) on 2026-10-15, disclosed to the SEC on 2026-10-16.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.48 | 6,654 | $762K | 66.3% |
| 2 | $115.39 | 3,046 | $351K | 30.6% |
| 3 | $116.30 | 300 | $35K | 3.0% |
| Total | $114.81 avg | 10,000 | $1.1M | 100% |
| Filing → |
| CORT | SELL | 2026-07-17 | $883K | — | Filing → |
| CORT | SELL | 2026-06-18 | $832K | — | Filing → |
| CORT | SELL | 2016-11-14 | $1.4M | — | Filing → |